|
|
5540 Ekwill Street
Santa Barbara, CA 93111 USA
phone:805.683.6761
fax:805.692.5432
|
| Symbol |
IMDC |
| Exchange |
Nasdaq |
| Founded |
0 |
| Employees |
1200 |
|
|
| www.inamed.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Breast and facial aesthetics and obesity intervention. |
|
| Management |
| Nicholas L. Teti, President & CEO; Vicente Trelles, COO; Declan Daly, CFO; Robert S. Vaters, Exec. VP of Strategy and Corp. Devel.; |
|
|
|
|
| Keywords |
| Aesthetics, plastic surgery, skin care |
|
|
|
|
| Description |
|
Inamed develops, manufactures and markets products for breast and facial aesthetics and obesity intervention. |
|
| Products / Services |
Inamed has three principal product lines: breast aesthetics (consisting primarily of breast implants and tissue expanders for use in plastic and reconstructive surgery), facial aesthetics (consisting primarily of collagen and hyaluronic acid-based dermal fillers for use in facial rejuvenation), and obesity intervention (consisting of products for use in treating severe and morbid obesity).
|
|
|
| Strategy |
In March 2005, Inamed announced a merger agreement with Medicis Pharmaceutical Corporation and Masterpiece Acquisition Corporation, a wholly-owned subsidiary of Medicis. Medicis is a leading independent specialty pharmaceutical company in the U.S. focusing primarily on the treatment of dermatological and podiatric conditions and aesthetics medicine.
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members